Clinical Trial Update: Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

View source ↗

Summary

Completed clinical trial evaluating a strategy that combines direct oral anticoagulants with antiplatelet drugs in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Antiplatelet agents
• Direct Oral Anticoagulants

Snippet

Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Atrial Fibrillation | Status: COMPLETED